Can Diabetic Neuropathy Be Modeled In Vitro?

Research output: Chapter in Book/Conference proceedingChapterpeer-review

Abstract

Diabetic neuropathy is a common secondary complication of diabetes that impacts on patient's health and well-being. Distal axon degeneration is a key feature of diabetic neuropathy, but the pathological changes which underlie axonal die-back are incompletely understood; despite decades of research a treatment has not yet been identified. Basic research must focus on understanding the complex mechanisms underlying changes that occur in the nervous system during diabetes. To this end, tissue culture techniques are invaluable as they enable researchers to examine the intricate mechanistic responses of cells to high glucose or other factors in order to better understand the pathogenesis of nerve dysfunction. This chapter describes the use of in vitro models to study a wide range of specific cellular effects pertaining to diabetic neuropathy including apoptosis, neurite outgrowth, neurodegeneration, activity, and bioenergetics. We consider problems associated with in vitro modeling and future refinement such as use of induced pluripotent stem cells and microfluidic technology.
Original languageEnglish
Title of host publicationInternational Review of Neurobiology
Subtitle of host publicationControversies In Diabetic Neuropathy
PublisherElsevier BV
Pages53-87
Number of pages34
Volume127
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Can Diabetic Neuropathy Be Modeled In Vitro?'. Together they form a unique fingerprint.

Cite this